GI Cancer Trials in Australia

The Australasian Gastro-Intestinal Trials Group (AGITG) is a leading multi-disciplinary collaborative group dedicated to conducting clinical trials for gastro-intestinal (GI) cancers. Established in 1991, the organization coordinates research across Australia and New Zealand to improve treatments and outcomes for patients with cancers of the esophagus, stomach, liver, pancreas, gallbladder, and bowel. AGITG operates as a non-profit academic research organization, collaborating with international research groups, pharmaceutical companies, and healthcare professionals. Through its fundraising arm, the GI Cancer Institute, it raises public awareness and funds to support its extensive portfolio of clinical research. The group's work encompasses a wide range of therapeutic modalities, including small molecules, monoclonal antibodies, and innovative surgical techniques.